In recent years, the trend in drug development has shifted from small molecule drugs to various innovative treatment modalities such as large molecule drugs, antibodies, as well as cellular and immune therapies. Traditional animal toxicology studies may struggle to accurately assess the safety of these new treatment methods. In contrast, non-human primate (NHPs) testing has shown more aligned responses to these novel biologics. As a leading entity in Japan's longest-standing non-clinical CRO field, SNBL is committed to creating an environment that facilitates the smooth development of drug therapies.
SNBL continuously strives to optimize NHPs testing while prioritizing animal welfare to establish a stable NHPs testing environment. Leveraging its 60 years of experience in the CRO field, SNBL has developed robust safety assessment tests for new treatment methods. This enables them to effectively address the demands for NHPs studies and offer specialized, customized testing plans at a competitive pricing advantage.
For further information about the testing services and assistance provided by SNBL, please feel free to contact us at your convenience.

At Healthcare+ Expo Taiwan 2023, GeneOnline, an global professional life science information platform, proudly launches BIODND, an AI-powered biotech industry database dedicated to providing a wealth of information on biotech and pharmaceutical companies, products, and technologies around the world, creating a platform for international cooperation and investment in the biopharma industry, and facilitating investors' access to comprehensive and in-depth information on the industry, leading to the emergence of more promising projects and partnerships.

The 2023 Healthcare EXPO Taiwan is set to take place from November 30 to December 3 at the Nangang Exhibition Center. Professionals and companies in the healthcare and health care fields will gather to share the latest technologies and innovations. At this highly anticipated event, HPB will showcase its globally unique Ezcaring P1 high-privacy AI intelligent care system and related peripheral support products, aiming to use technology to create a high-quality life from infancy to old age.

Cancer stands as the second leading cause of global mortality, and existing hematologic tumor markers exhibit insufficient specificity and sensitivity for early-stage cancer detection, hovering at around 50%. Marker X Utilizes high-resolution mass spectrometry to analyze protein expression and modifications, coupled with nearly three thousand clinical blood samples, artificial intelligence (AI) machine learning, and a globally exclusive multi-indicator algorithm, a novel and efficient cancer indicator has been developed. Early screening indicators for lung cancer, colorectal cancer, breast cancer, and esophageal cancer have been successfully established, with an accuracy exceeding 95%.
The early detection of cancer typically leads to higher treatment success rates, shortened therapeutic durations, and reduced financial burdens associated with extensive treatment expenses. With a mere 3ml blood draw, test results can be obtained within 10 working days. The sensitivity of the examination encompasses the earliest stages of in situ carcinoma and first-stage cancer. In comparison to other targeted tests, cancer proteomics more accurately reflects the current physiological state, thereby reducing the risk of misdiagnosis.

Huijia Health with patented core technology- Non-invasive Fiber Optic Physiological Monitoring Technology (nFOPT®) using the principle of total reflection of optical fiber, there is no electromagnetic field change (no electromagnetic wave) in each action.

Medical laboratories should establish internal quality management systems and conduct external inter-laboratory quality assessments to meet clinical quality control standards. In the international laboratory accreditation standards, external inter-laboratory quality assessment, called accuracy assessment, is often called proficiency testing (PT), and the Taiwan Society of Laboratory Medicine (TSLM) began to provide PT services in 2000. In March 2011, it was authenticated by the Taiwan Accreditation Foundation, with the accreditation ID P008. TSLM complies with the International Laboratory Accreditation Cooperation (ILAC) document ISO/IEC 17043:2010. The results of proficiency testing are recorded in the "Proficiency Testing Assessment Report" and are accompanied by a "Summary Report". These reports are published to illustrate the combined results and to serve as valuable educational resources.

AmLife International Co., Ltd. is a sleep and wellness expert spanning across 6 countries. Continuously collaborating with international authorities in sleep medicine, the company is dedicated to promoting health and wellness activities. With a research and development facility in Japan, they specialize in medical equipment that combines Japanese electric potential therapy with bedding. Their mission is to help everyone enjoy high-quality sleep, creating health through sleep, and improving chronic conditions such as insomnia, hypertension, and cardiovascular issues, ultimately enhancing the quality of life.

At the Taiwan Medical Technology Expo, an international professional medical team is present, offering complimentary cutting-edge cardiovascular arterial hardening tests, microcirculation tests, and consultations. This initiative, valued at NT$3,800, safeguards the cardiovascular health of the public. In just 90 seconds, individuals can gain insight into their cardiovascular health and receive optimal health advice and solutions.

Professional electric potential therapists and sleep care specialists are on-site, providing the opportunity for the public to experience the DeepZleep smart sleep wellness device. Witness the improvement in cardiovascular conditions firsthand.

AmLife is a sleep and wellness expert spanning 6 countries, consistently collaborating with international authorities in sleep medicine. With a research and development facility in Japan, they integrate Japanese electric potential therapy with bedding, dedicated to helping everyone enjoy high-quality sleep. Through addressing chronic conditions like insomnia, hypertension, and cardiovascular problems, AmLife aims to enhance the quality of life.

Guarding cardiovascular health is crucial, and AmLife is at the forefront of providing solutions.

Taiwan ASA Biotechnology Co., Ltd. has developed an autologous multilineages potential cells (AMPC) product. Major process was completed in a fully enclosed system in the GTP laboratory without adding any antibiotics, growth factors or genetic manipulation. After 4 days, cells are natural transformed into stem cells , and clinical autologous intravenous infusion is performed. The cell products of AMPC are highly safe.

Excipients play an integral role in the pharmaceutical industry. It's vital to drug product texture, bioavailability and safety. 2023 Healthcare EXPO．TAIWAN, held from 11/30 to 12/3, brings together the world's leading medical technology companies to provide a platform for industry professionals to learn, communicate and cooperate, and jointly promote the development of the medical field. Wei Ming Pharmaceutical, as an excipient expert, will participate in this event with a number of internationally renowned pharmaceutical raw materials companies to jointly showcase the most advanced excipient technologies ,products and share best practices and experiences in the pharmaceutical process.

The most accurate epigenetic clock is here!

GB CellBio™ utilizes a patented membrane separation method called iFiltration™. This method efficiently captures circulating tumor cells in human blood without damaging cell structure and preserves target antigens and specific markers.

SmartMotion NIR Detox Capsule is a photohyperthermia equipment that simulates the full wavelength of solar spectrum "600nm~1400nm".

Instead of using invasive endoscopy, SAA Protein Test, by the simple blood draw, is an excellent option for early gastrointestinal cancer screening.

Leadgene Biomedical, a trailblazer in the biomedical field, has carved a niche in recombinant protein and antibody manufacturing, establishing itself as a leader in the industry with its innovative Indoxyl Sulfate (IS) ELISA Kit.